LIFEVANTAGE CORP Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-06-30 was 1.00K shares.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-03-31 was 21.00K shares, a 4.55% decline year-over-year.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-12-31 was 0.00 shares.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-09-30 was 13.00K shares, a 40.91% decline year-over-year.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for fiscal 2026 was 35.00K shares, a 20.45% decline from fiscal 2025.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 44.00K shares.
- LIFEVANTAGE CORP stock issued during period, shares, employee stock purchase plans for fiscal 2019 was 0.00 shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-06-30 | 1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | 35.00K shares 10-K · filed 2026-08-27 |
| 2026-03-31 | 21.00K shares 10-Q · filed 2026-05-06 | 34.00K shares derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | 35.00K shares derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | 13.00K shares 10-Q · filed 2025-11-04 | 35.00K shares derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | 44.00K shares 10-K · filed 2026-08-27 |
| 2025-03-31 | 22.00K shares 10-Q · filed 2026-05-06 | |
| 2024-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | |
| 2024-09-30 | 22.00K shares 10-Q · filed 2025-11-04 | |
| 2024-03-31 | 25.00K shares 10-Q · filed 2025-05-06 | |
| 2023-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-05 | |
| 2023-09-30 | 39.00K shares 10-Q · filed 2024-10-29 | |
| 2023-03-31 | 40.00K shares 10-Q · filed 2024-05-02 | |
| 2022-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-30 | |
| 2022-09-30 | 36.00K shares 10-Q · filed 2023-11-09 | |
| 2022-03-31 | 41.00K shares 10-Q · filed 2023-05-04 | |
| 2021-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | |
| 2021-09-30 | 27.00K shares 10-Q · filed 2022-11-02 | |
| 2021-03-31 | 36.00K shares 10-Q · filed 2022-05-03 | |
| 2020-09-30 | 23.00K shares 10-Q · filed 2021-04-29 | |
| 2020-03-31 | 31.00K shares 10-Q · filed 2020-05-05 | |
| 2019-09-30 | 32.00K shares 10-Q · filed 2020-05-05 | |
| 2019-06-30 | 0.00 shares 10-K · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |